Details of the Competitor
General Information of Competitor
The Competitor Interaction Atlas
Probe(s) Related This Competitor
ABPP Probe
| Probe Name | Structure | Concentration | Cell-system | Ref | |
|---|---|---|---|---|---|
|
IPM Probe Info |
![]() |
100 uM | Human breast adenocarcinoma cell lysate (MDA-MB-231) | [1] | |
|
IA-alkyne Probe Info |
![]() |
200 uM | Human T acute lymphoblastic leukemia cell lysate (Jurkat) | [2] | |
|
DBIA Probe Info |
![]() |
500 uM | Human colon carcinoma cell lysate (HCT 116) | [3] | |
Target(s) List of this Competitor
|
3853 Enzyme Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
887 Transporter and channel Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
776 Transcription factor Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
52 GPCR Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
156 Immunoglobulin Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
66 Cytokine and receptor Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
4544 Other Competed by This
Competitor
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Information of The Labelling Profiles of This Competitor
DBIA
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon carcinoma [ICD-11:2B90] | ||||
| Human colon carcinoma cell lysate (HCT 116) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 2 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| T acute lymphoblastic leukemia [ICD-11:2A90] | ||||
| Human T acute lymphoblastic leukemia cell lysate (Jurkat) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 3 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Normal | ||||
| Human normal cell lysate (HEK-293T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 4 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Normal | ||||
| Human normal cell lysate (HEK-293T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 5 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Normal | ||||
| Human normal cell lysate (HEK-293T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 6 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Normal | ||||
| Human normal cell lysate (HEK-293T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 7 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Normal | ||||
| Human normal cell lysate (HEK-293T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 8 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cell lysate (22RV1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 9 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (42-MG-BA) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 10 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| B acute lymphoblastic leukemia [ICD11: 2B33] | ||||
| Human b acute lymphoblastic leukemia cell lysate (697) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 11 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Renal cell carcinoma [ICD11: 2C90] | ||||
| Human renal cell carcinoma cell lysate (769-P) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 12 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Renal cell carcinoma [ICD11: 2C90] | ||||
| Human renal cell carcinoma cell lysate (786-O) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 13 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Thyroid gland anaplastic carcinoma [ICD11: 2D10] | ||||
| Human thyroid gland anaplastic carcinoma cell lysate (8305C) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 14 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Thyroid gland anaplastic carcinoma [ICD11: 2D10] | ||||
| Human thyroid gland anaplastic carcinoma cell lysate (8505C) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 15 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (A101D) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 16 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (A-172) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 17 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Rhabdomyosarcoma [ICD11: 2B55] | ||||
| Human rhabdomyosarcoma cell lysate (A204) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 18 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (A2058) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 19 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovary endometrioid adenocarcinoma [ICD11: 2C73] | ||||
| Human ovary endometrioid adenocarcinoma cell lysate (A2780) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 20 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Amelanotic melanoma [ICD-11:2C30] | ||||
| Human amelanotic melanoma cell lysate (A-375) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 21 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Amelanotic melanoma [ICD-11:2C30] | ||||
| Human amelanotic melanoma cell lysate (A375.S2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 22 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Diffuse large B-cell lymphoma [ICD11: 2A81] | ||||
| Human diffuse large B-cell lymphoma cell lysate (A3-KAW) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 23 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Skin squamous cell carcinoma [ICD-11:2C31] | ||||
| Human skin squamous cell carcinoma cell lysate (A431) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 24 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Renal cancer [ICD11: 2C90] | ||||
| Human renal cancer cell lysate (A498) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 25 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (A-549) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 26 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Rhabdomyosarcoma [ICD11: 2B55] | ||||
| Human rhabdomyosarcoma cell lysate (A673) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 27 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (ABC-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 28 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (AGS) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 29 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial adenocarcinoma [ICD-11:2C76] | ||||
| Human endometrial adenocarcinoma cell lysate (AN3-CA) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 30 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (AU565) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 31 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Oral squamous cell carcinoma [ICD11: 2B6E] | ||||
| Human oral squamous cell carcinoma cell lysate (BICR-22) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 32 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX142) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 33 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX211) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 34 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX250) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 35 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX29) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 36 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX330) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 37 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX390) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 38 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX394) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 39 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX401) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 40 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX50) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 41 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX68) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 42 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD-11:2C82] | ||||
| Human breast cancer cell lysate (BRX82) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 43 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (BT-549) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 44 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic ductal adenocarcinoma cell lysate (BxPC-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 45 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Amelanotic melanoma [ICD-11:2C30] | ||||
| Human amelanotic melanoma cell lysate (C32) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 46 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cervical cancer [ICD11: 2C77] | ||||
| Human cervical cancer cell lysate (C-4-II) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 47 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Clear cell renal cell carcinoma [ICD11: 2C90] | ||||
| Human clear cell renal cell carcinoma cell lysate (Caki-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 48 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast carcinoma [ICD-11:2C60] | ||||
| Human breast carcinoma cell lysate (CAL-120) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 49 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast carcinoma [ICD-11:2C60] | ||||
| Human breast carcinoma cell lysate (CAL-148) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 50 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Oral cancer [ICD11: 2B6E] | ||||
| Human oral cancer cell lysate (CAL-27) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 51 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Oral squamous cell carcinoma [ICD11: 2B6E] | ||||
| Human oral squamous cell carcinoma cell lysate (CAL-33) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 52 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast carcinoma [ICD-11:2C60] | ||||
| Human breast carcinoma cell lysate (CAL-51) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 53 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Thyroid gland anaplastic carcinoma [ICD11: 2D10] | ||||
| Human thyroid gland anaplastic carcinoma cell lysate (CAL-62) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 54 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Osteosarcoma [ICD-11:2B51] | ||||
| Human osteosarcoma cell lysate (CAL-72) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 55 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chondrosarcoma [ICD11: 2B50] | ||||
| Human chondrosarcoma cell lysate (CAL-78) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 56 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung squamous cell carcinoma [ICD-11:2C25] | ||||
| Human lung squamous cell carcinoma cell lysate (Calu-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 57 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (Calu-6) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 58 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (CAMA-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 59 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (Caov-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 60 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cervical cancer [ICD11: 2C77] | ||||
| Human cervical cancer cell lysate (Ca-Ski) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 61 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (CCK-81) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 62 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (CC-LP-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 63 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (CC-SW-1 ) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 64 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic ductal adenocarcinoma cell lysate (CFPAC-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 65 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (CHL-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 66 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Down syndrome [ICD11: LD40] | ||||
| Human down syndrome cell lysate (CMK) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 67 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (COLO 320) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 68 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon carcinoma [ICD-11:2B90] | ||||
| Human colon carcinoma cell lysate (COLO-678) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 69 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (COLO-679) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 70 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (COLO-792) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 71 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (COLO-800) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 72 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (COLO-829) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 73 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (COLO 853) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 74 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung cancer [ICD11: 2C25] | ||||
| Human lung cancer cell lysate (COR-L23) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 75 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (COR-L88) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 76 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Medulloblastoma [ICD11: 2A00] | ||||
| Human medulloblastoma cell lysate (D283 Med) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 77 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic cancer [ICD11: 2C10] | ||||
| Human pancreatic cancer cell lysate (DAN-G) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 78 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Medulloblastoma [ICD11: 2A00] | ||||
| Human medulloblastoma cell lysate (Daoy) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 79 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Anaplastic large cell lymphoma [ICD11: 2A90] | ||||
| Human anaplastic large cell lymphoma cell lysate (DEL) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 80 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pharyngeal squamous cell carcinoma [ICD11: 2B6D] | ||||
| Human pharyngeal squamous cell carcinoma cell lysate (Detroit 562) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 81 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cervical cancer [ICD11: 2C77] | ||||
| Human cervical cancer cell lysate (DoTc2-4510) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 82 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cell lysate (DU145) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 83 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (DU-4475) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 84 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (ECC2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 85 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (EFO-21) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 86 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian mucinous adenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian mucinous adenocarcinoma cell lysate (EFO-27) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 87 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (EGI-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 88 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic eosinophilic leukaemia [ICD11: 2A20] | ||||
| Human chronic eosinophilic leukaemia cell lysate (EoL-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 89 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (ETK-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 90 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hypopharyngeal squamous cell carcinoma [ICD11: 2B6D.0] | ||||
| Human hypopharyngeal squamous cell carcinoma cell lysate (FaDu) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 91 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Thyroid gland follicular carcinoma [ICD11: 2D10] | ||||
| Human thyroid gland follicular carcinoma cell lysate (FTC-133) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 92 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| High grade ovarian serous adenocarcinoma [ICD11: 2B5D] | ||||
| Human high grade ovarian serous adenocarcinoma cell lysate (FU-OV-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 93 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (G-361) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 94 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Wilms tumor [ICD11: 2C90] | ||||
| Human wilms tumor cell lysate (G-401) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 95 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Kidney cancer [ICD11: 2C90] | ||||
| Human kidney cancer cell lysate (G-402) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 96 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gallbladder cancer [ICD11: 2C13] | ||||
| Human gallbladder cancer cell lysate (G-415) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 97 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (GAMG) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 98 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (GB-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 99 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (GB-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 100 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HCC1143) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 101 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HCC1187) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 102 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HCC1395) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 103 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HCC1419) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 104 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung squamous cell carcinoma [ICD-11:2C25] | ||||
| Human lung squamous cell carcinoma cell lysate (HCC15) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 105 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD11: 2C60-2C65] | ||||
| Human breast cancer cell lysate (HCC1806) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 106 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HCC1937) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 107 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HCC1954) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 108 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (HCC44) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 109 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HCC70) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 110 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (HCC827 CDX model (CDX: HA1; Afatinib resistant)) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 111 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (HCT 15) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 112 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute myeloid leukemia [ICD-11:2A60] | ||||
| Human acute myeloid leukemia cell lysate (HD-MY-Z) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 113 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast ductal carcinoma [ICD11: 2C61] | ||||
| Human breast ductal carcinoma cell lysate (HDQ-P1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 114 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial adenocarcinoma [ICD-11:2C76] | ||||
| Human endometrial adenocarcinoma cell lysate (HEC-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 115 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Erythroleukemia [ICD11: 2A60] | ||||
| Human erythroleukemia cell lysate (HEL) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 116 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Erythroleukemia [ICD11: 2A60] | ||||
| Human erythroleukemia cell lysate (HEL 92.1.7) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 117 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD11: 2C12] | ||||
| Human hepatocellular carcinoma cell lysate (Hep 3B2.1-7) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 118 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatoblastoma [ICD-11:DB91] | ||||
| Human hepatoblastoma cell lysate (Hep-G2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 119 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic lymphocytic leukemia [ICD11: 2A82] | ||||
| Human chronic lymphocytic leukemia cell lysate (HG-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 120 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (HGC-27) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 121 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (HKGZ-CC) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 122 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD-11:2C12] | ||||
| Human hepatocellular carcinoma cell lysate (HLF) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 123 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (HMCB) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 124 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD11: 2C60-2C65] | ||||
| Human breast cancer cell lysate (Hs 578T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 125 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Normal | ||||
| Human normal cell lysate (Hs 839.T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 126 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (Hs 936.T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 127 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (Hs 936.T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 128 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Oral squamous cell carcinoma [ICD11: 2B6E] | ||||
| Human oral squamous cell carcinoma cell lysate (HSC-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 129 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Oral squamous cell carcinoma [ICD11: 2B6E] | ||||
| Human oral squamous cell carcinoma cell lysate (HSC-4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 130 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Diffuse large B-cell lymphoma [ICD11: 2A81] | ||||
| Human diffuse large B-cell lymphoma cell lysate (HT) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 131 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Fibrosarcoma [ICD11: 2B53] | ||||
| Human fibrosarcoma cell lysate (HT-1080 (FAP expression)) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 132 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon carcinoma [ICD-11:2B90] | ||||
| Human colon carcinoma cell lysate (HT115) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 133 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (HT-1197) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 134 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (HT-1376) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 135 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon cancer [ICD11: 2C82] | ||||
| Human colon cancer cell lysate (HT29) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 136 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cervical cancer [ICD11: 2C77] | ||||
| Human cervical cancer cell lysate (HT-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 137 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Liver bile duct carcinoma [ICD11: 2C12] | ||||
| Human liver bile duct carcinoma cell lysate (HuCCT-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 138 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD-11:2C12] | ||||
| Human hepatocellular carcinoma cell lysate (HuH-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 139 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (HuH-28) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 140 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD-11:2C12] | ||||
| Human hepatocellular carcinoma cell lysate (Huh-7) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 141 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic adenocarcinoma cell lysate (HuP-T3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 142 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic adenocarcinoma cell lysate (HuP-T4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 143 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC10) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 144 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC106) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 145 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC108) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 146 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC11) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 147 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC12) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 148 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC13-7) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 149 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC18) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 150 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC19) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 151 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC20) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 152 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC21) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 153 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC24) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 154 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC26) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 155 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 156 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 157 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC8) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 158 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (ICC9) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 159 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (IGR-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 160 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (IGR-37) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 161 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (IGR-39) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 162 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovary endometrioid adenocarcinoma [ICD11: 2C73] | ||||
| Human ovary endometrioid adenocarcinoma cell lysate (IGROV-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 163 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (IM95) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 164 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (IPC-298) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 165 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial adenocarcinoma [ICD-11:2C76] | ||||
| Human endometrial adenocarcinoma cell lysate (Ishikawa (Heraklio) 02 ER-) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 166 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (J82) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 167 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Mantle cell lymphoma [ICD11: 2A85] | ||||
| Human mantle cell lymphoma cell lysate (JeKo-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 168 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD11: 2C12] | ||||
| Human hepatocellular carcinoma cell lysate (JHH-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 169 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD11: 2C12] | ||||
| Human hepatocellular carcinoma cell lysate (JHH-4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 170 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD11: 2C12] | ||||
| Human hepatocellular carcinoma cell lysate (JHH-6) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 171 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD-11:2C12] | ||||
| Human hepatocellular carcinoma cell lysate (JHH-7) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 172 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| B acute lymphoblastic leukemia [ICD11: 2B33] | ||||
| Human b acute lymphoblastic leukemia cell lysate (JM-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 173 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| T acute lymphoblastic leukemia [ICD-11:2A90] | ||||
| Human T acute lymphoblastic leukemia cell lysate (Jurkat) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 174 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic myelogenous leukemia [ICD11: 2A20] | ||||
| Human chronic myelogenous leukemia cell lysate (JURL-MK1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 175 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| B-cell prolymphocytic leukemia [ICD11: 2A70] | ||||
| Human b-cell prolymphocytic leukemia cell lysate (JVM-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 176 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Anaplastic large cell lymphoma [ICD11: 2A90] | ||||
| Human anaplastic large cell lymphoma cell lysate (Karpas-299) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 177 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Diffuse large B-cell lymphoma [ICD11: 2A81] | ||||
| Human diffuse large B-cell lymphoma cell lysate (Karpas-422) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 178 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Myeloid leukaemia [ICD11: 2B33] | ||||
| Human myeloid leukaemia cell lysate (Kasumi-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 179 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| B acute lymphoblastic leukemia [ICD11: 2B33] | ||||
| Human b acute lymphoblastic leukemia cell lysate (Kasumi-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 180 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric signet ring cell adenocarcinoma [ICD11: 2B72] | ||||
| Human gastric signet ring cell adenocarcinoma cell lysate (KATO III) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 181 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Neuroblastoma [ICD-11:2D50] | ||||
| Human neuroblastoma cell lysate (Kelly) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 182 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Liver cancer [ICD11: 2C12] | ||||
| Human liver cancer cell lysate (KMCH-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 183 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Clear cell renal cell carcinoma [ICD11: 2C90] | ||||
| Human clear cell renal cell carcinoma cell lysate (KMRC-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 184 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Clear cell renal cell carcinoma [ICD11: 2C90] | ||||
| Human clear cell renal cell carcinoma cell lysate (KMRC-20) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 185 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Clear cell renal cell carcinoma [ICD11: 2C90] | ||||
| Human clear cell renal cell carcinoma cell lysate (KMRC3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 186 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Plasma cell myeloma [ICD-11:2A83] | ||||
| Human plasma cell myeloma cell lysate (KMS11) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 187 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Plasma cell myeloma [ICD-11:2A83] | ||||
| Human plasma cell myeloma cell lysate (KMS-12-BM) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 188 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Plasma cell myeloma [ICD-11:2A83] | ||||
| Human plasma cell myeloma cell lysate (KMS-27) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 189 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (KNS-42) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 190 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (KNS-81-FD) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 191 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Adult acute myeloid leukemia [ICD11: 2A60] | ||||
| Human adult acute myeloid leukemia cell lysate (K052) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 192 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic cancer [ICD11: 2C10] | ||||
| Human pancreatic cancer cell lysate (KP-4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 193 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast cancer [ICD11: 2C60-2C65] | ||||
| Human breast cancer cell lysate (KPL-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 194 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Adrenal cancer [ICD11: 2D11] | ||||
| Human adrenal gland neuroblastoma cell lysate (KP-N-YN) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 195 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (KU-19-19) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 196 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (KURAMOCHI) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 197 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Embryonal rhabdomyosarcoma [ICD11: 2B55] | ||||
| Human embryonal rhabdomyosarcoma cell lysate (KYM-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 198 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (KYSE-150) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 199 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (KYSE-180) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 200 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (KYSE-30) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 201 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (KYSE-410) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 202 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (KYSE-510) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 203 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hodgkin lymphoma [ICD11: 2B30] | ||||
| Human hodgkin lymphoma cell lysate (L-428) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 204 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (LN-18) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 205 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (LN-229) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 206 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cell lysate (LNCaP-Clone-FGC) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 207 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Amelanotic melanoma [ICD-11:2C30] | ||||
| Human amelanotic melanoma cell lysate (LOX IMVI) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 208 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (LS-123) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 209 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon carcinoma [ICD-11:2B90] | ||||
| Human colon carcinoma cell lysate (LS180) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 210 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cecum adenocarcinoma [ICD-11:2B90] | ||||
| Human cecum adenocarcinoma cell lysate (LS-513) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 211 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung giant cell carcinoma [ICD11: 2C25] | ||||
| Human lung giant cell carcinoma cell lysate (Lu-65) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 212 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung squamous cell carcinoma [ICD-11:2C25] | ||||
| Human lung squamous cell carcinoma cell lysate (LUDLU-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 213 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian mucinous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian mucinous cystadenocarcinoma cell lysate (MCAS) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 214 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Merkel cell carcinoma [ICD11: 2C34] | ||||
| Human merkel cell carcinoma cell lysate (MCC13) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 215 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Merkel cell carcinoma [ICD11: 2C34] | ||||
| Human merkel cell carcinoma cell lysate (MCC26) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 216 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Invasive breast carcinoma [ICD-11:2C60] | ||||
| Human invasive breast carcinoma cell lysate (MCF-7) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 217 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast carcinoma [ICD-11:2C60] | ||||
| Human breast carcinoma cell lysate (MDA-MB-157) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 218 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (MDA-MB-231) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 219 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ductal carcinoma [ICD11: 2C61] | ||||
| Human ductal carcinoma cell lysate (MDA-MB-436) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 220 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (MDA-MB-453) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 221 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (MDA-MB-468) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 222 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon carcinoma [ICD-11:2B90] | ||||
| Human colon carcinoma cell lysate (MDST8) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 223 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Chronic lymphocytic leukemia [ICD11: 2A82] | ||||
| Human chronic lymphocytic leukemia cell lysate (MEC-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 224 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (CHL1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 225 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (COLO792) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 226 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (MEL-HO) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 227 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (MEL-JUSO) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 228 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (MeWo) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 229 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial adenocarcinoma [ICD-11:2C76] | ||||
| Human endometrial adenocarcinoma cell lysate (MFE-280) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 230 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial adenocarcinoma [ICD-11:2C76] | ||||
| Human endometrial adenocarcinoma cell lysate (MFE-296) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 231 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial cancer [ICD11: 2C76] | ||||
| Human endometrial cancer cell lysate (MFE-319) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 232 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Normal | ||||
| Human normal cell lysate (MG984) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 233 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (MGG123) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 234 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (MGG23) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 235 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (MGG75) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 236 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (DM93) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 237 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (A101D) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 238 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (A2058) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 239 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (CHL1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 240 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (COLO792) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 241 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (G361) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 242 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (HMCB) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 243 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (Hs 936.T) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 244 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (IGR37) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 245 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (IGR39) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 246 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (MEL167) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 247 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (MEL182) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 248 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (MELHO) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 249 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (MEWO) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 250 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (RVH421) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 251 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (SH4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 252 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (SKMEL2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 253 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (SKMEL24) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 254 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (SKMEL3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 255 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (UACC257) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 256 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (UACC62) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 257 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (WM115) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 258 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (WM266-4 ) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 259 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung carcinoma cell lysate (RAW264.7) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 260 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic ductal adenocarcinoma cell lysate (MIA PaCa-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 261 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (MKN-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 262 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (MKN45) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 263 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute myeloid leukemia [ICD-11:2A60] | ||||
| Human acute myeloid leukemia cell lysate (MOLM-13) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 264 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Adult acute myeloid leukemia [ICD11: 2A60] | ||||
| Human adult acute myeloid leukemia cell lysate (MOLM-16) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 265 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute monocytic leukemia [ICD-11:2A60] | ||||
| Human acute monocytic leukemia cell lysate (MONO-MAC-6) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 266 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute monocytic leukemia [ICD-11:2A60] | ||||
| Human acute monocytic leukemia cell lysate (MONO-MAC-6) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 267 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pleural biphasic mesothelioma [ICD11: 2C26] | ||||
| Human pleural biphasic mesothelioma cell lysate (MSTO-211H) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 268 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute monocytic leukemia [ICD-11:2A60] | ||||
| Human acute monocytic leukemia cell lysate (MV4-11) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 269 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| B acute lymphoblastic leukemia [ICD11: 2B33] | ||||
| Human b acute lymphoblastic leukemia cell lysate (NALM-6) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 270 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Neuroblastoma [ICD-11:2D50] | ||||
| Human neuroblastoma cell lysate (NB1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 271 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (NCI-H1048) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 272 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung large cell carcinoma [ICD-11:2C25] | ||||
| Human lung large cell carcinoma cell lysate (NCI-H1155) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 273 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung large cell carcinoma [ICD-11:2C25] | ||||
| Human lung large cell carcinoma cell lysate (NCI-H1299) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 274 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (NCI-H146) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 275 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H1650) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 276 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H1666) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 277 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung squamous cell carcinoma [ICD-11:2C25] | ||||
| Human lung squamous cell carcinoma cell lysate (NCI-H1703) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 278 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H1792) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 279 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H1793) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 280 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCl-H1944) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 281 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (NCI-H196) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 282 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H1975) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 283 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pleural mesothelioma [ICD11: 2C26] | ||||
| Human pleural mesothelioma cell lysate (NCI-H2052) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 284 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H2122) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 285 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung squamous cell carcinoma [ICD-11:2C25] | ||||
| Human lung squamous cell carcinoma cell lysate (NCI-H2170) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 286 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Non-small cell lung cancer [ICD11: 2C25] | ||||
| Human non-small cell lung cancer cell lysate (NCI-H2172) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 287 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung squamous cell carcinoma [ICD-11:2C25] | ||||
| Human lung squamous cell carcinoma cell lysate (NCI-H2286) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 288 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H2291) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 289 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H23) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 290 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (NCI-H3122) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 291 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung cancer [ICD11: 2C25] | ||||
| Human lung cancer cell lysate (NCI-H358) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 292 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (NCI-H446) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 293 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (NCI-H82) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 294 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric tubular adenocarcinoma [ICD11: 2.00E+92] | ||||
| Human gastric tubular adenocarcinoma cell lysate (NCI-N87) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 295 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| High grade ovarian serous adenocarcinoma [ICD11: 2B5D] | ||||
| Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 296 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute monocytic leukemia [ICD-11:2A60] | ||||
| Human acute monocytic leukemia cell lysate (NOMO-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 297 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (NUGC-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 298 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (OAW-28) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 299 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (OAW-42) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 300 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute myeloid leukemia [ICD-11:2A60] | ||||
| Human acute myeloid leukemia cell lysate (OCI-AML-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 301 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute myeloid leukemia [ICD-11:2A60] | ||||
| Human acute myeloid leukemia cell lysate (OCI-AML-5) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 302 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Diffuse large B-cell lymphoma [ICD11: 2A81] | ||||
| Human diffuse large B-cell lymphoma cell lysate (OCI-Ly3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 303 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gallbladder cancer [ICD11: 2C13] | ||||
| Human gallbladder cancer cell lysate (OCUG-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 304 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric signet ring cell adenocarcinoma [ICD11: 2B72] | ||||
| Human gastric signet ring cell adenocarcinoma cell lysate (OCUM-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 305 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Barrett adenocarcinoma [ICD11: 2B70] | ||||
| Human barrett adenocarcinoma cell lysate (OE33) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 306 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Medulloblastoma [ICD11: 2A00] | ||||
| Human medulloblastoma cell lysate (ONS-76) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 307 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Plasma cell myeloma [ICD-11:2A83] | ||||
| Human plasma cell myeloma cell lysate (OPM-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 308 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Clear cell renal cell carcinoma [ICD11: 2C90] | ||||
| Human clear cell renal cell carcinoma cell lysate (OS-RC-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 309 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (OV56) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 310 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian cancer [ICD11: 2C73] | ||||
| Human ovarian cancer cell lysate (OV-90) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 311 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian cancer [ICD11: 2C73] | ||||
| Human ovarian cancer cell lysate (OVCA429) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 312 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian cancer [ICD11: 2C73] | ||||
| Human ovarian cancer cell lysate (OVCAR-4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 313 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (OVCAR-5) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 314 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| High grade ovarian serous adenocarcinoma [ICD11: 2B5D] | ||||
| Human high grade ovarian serous adenocarcinoma cell lysate (OVCAR-8) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 315 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian clear cell adenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian clear cell adenocarcinoma cell lysate (OVISE) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 316 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovary endometrioid adenocarcinoma [ICD11: 2C73] | ||||
| Human ovary endometrioid adenocarcinoma cell lysate (OVK-18) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 317 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| High grade ovarian serous adenocarcinoma [ICD11: 2B5D] | ||||
| Human high grade ovarian serous adenocarcinoma cell lysate (OVKATE) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 318 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian clear cell adenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian clear cell adenocarcinoma cell lysate (OVTOKO) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 319 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (OZ) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 320 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute myeloid leukemia [ICD-11:2A60] | ||||
| Human acute myeloid leukemia cell lysate (P31-FUJ) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 321 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic ductal adenocarcinoma cell lysate (Panc 04.03) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 322 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic ductal adenocarcinoma cell lysate (PANC-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 323 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic adenocarcinoma cell lysate (PaTu 8988t) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 324 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung adenocarcinoma [ICD-11:2C25] | ||||
| Human lung adenocarcinoma cell lysate (PC-14) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 325 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cell lysate (PC-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 326 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian cancer [ICD11: 2C73] | ||||
| Human ovarian cancer cell lysate (PEO1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 327 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| T acute lymphoblastic leukemia [ICD-11:2A90] | ||||
| Human T acute lymphoblastic leukemia cell lysate (PF-382) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 328 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Neuroectodermal tumor [ICD11: 2A00] | ||||
| Human neuroectodermal tumor cell lysate (PFSK-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 329 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (RBE) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 330 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Renal cell carcinoma [ICD11: 2C90] | ||||
| Human renal cell carcinoma cell lysate (RCC10RGB) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 331 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Rhabdomyosarcoma [ICD11: 2B55] | ||||
| Human rhabdomyosarcoma cell lysate (RD) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 332 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Mantle cell lymphoma [ICD11: 2A85] | ||||
| Human mantle cell lymphoma cell lysate (REC-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 333 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| B acute lymphoblastic leukemia [ICD11: 2B33] | ||||
| Human b acute lymphoblastic leukemia cell lysate (Reh) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 334 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Alveolar rhabdomyosarcoma [ICD11: 2B55] | ||||
| Human alveolar rhabdomyosarcoma cell lysate (SJRH30) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 335 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Alveolar rhabdomyosarcoma [ICD11: 2B55] | ||||
| Human alveolar rhabdomyosarcoma cell lysate (Rh41) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 336 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian leiomyosarcoma [ICD11: 2C73] | ||||
| Human ovarian leiomyosarcoma cell lysate (RKN) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 337 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon carcinoma [ICD-11:2B90] | ||||
| Human colon carcinoma cell lysate (RKO) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 338 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Diffuse large B-cell lymphoma [ICD11: 2A81] | ||||
| Human diffuse large B-cell lymphoma cell lysate (RL) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 339 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial cancer [ICD11: 2C76] | ||||
| Human endometrial cancer cell lysate (RL95-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 340 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD11: 2C30] | ||||
| Human melanoma cell lysate (RPMI-7951) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 341 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Plasma cell myeloma [ICD-11:2A83] | ||||
| Human plasma cell myeloma cell lysate (RPMI-8226) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 342 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (RT-112) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 343 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (RVH-421) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 344 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Osteosarcoma [ICD-11:2B51] | ||||
| Human osteosarcoma cell lysate (SAOS-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 345 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (SBC-5) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 346 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Squamous carcinoma [ICD11: 2B6A] | ||||
| Human squamous carcinoma cell lysate (SCC-25) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 347 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (SF-295) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 348 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (SG231) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 349 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (SH-4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 350 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (SHP-77) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 351 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cervical cancer [ICD11: 2C77] | ||||
| Human cervical cancer cell lysate (SiSo) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 352 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Osteosarcoma [ICD-11:2B51] | ||||
| Human osteosarcoma cell lysate (SJSA-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 353 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ewing sarcoma [ICD11: 2B52] | ||||
| Human ewing sarcoma cell lysate (SK-ES1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 354 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatoma [ICD11: 2C12] | ||||
| Human hepatoma cell lysate (SK-HEP1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 355 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (SK-MEL-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 356 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (SK-MEL-24) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 357 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (SK-MEL-28) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 358 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (SK-MEL3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 359 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (SK-MEL-30) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 360 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (SK-MEL-5) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 361 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Plasma cell myeloma [ICD-11:2A83] | ||||
| Human plasma cell myeloma cell lysate (SK-MM-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 362 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Uterine corpus leiomyosarcoma [ICD11: 2.00E+86] | ||||
| Human uterine corpus leiomyosarcoma cell lysate (SKN) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 363 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Neuroblastoma [ICD-11:2D50] | ||||
| Human neuroblastoma cell lysate (SK-N-AS) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 364 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Neuroepithelioma [ICD11: 2A00] | ||||
| Human neuroepithelioma cell lysate (SK-N-MC) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 365 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (SK-OV-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 366 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Endometrial adenocarcinoma [ICD-11:2C76] | ||||
| Human endometrial adenocarcinoma cell lysate (SNG-M) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 367 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (SNU-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 368 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (SNU-1079) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 369 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hilar cholangiocarcinoma [ICD11: 2C18] | ||||
| Human hilar cholangiocarcinoma cell lysate (SNU-1196) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 370 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (SNU-245) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 371 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gallbladder cancer [ICD11: 2C13] | ||||
| Human gallbladder cancer cell lysate (SNU-308) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 372 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD-11:2C12] | ||||
| Human hepatocellular carcinoma cell lysate (SNU-423) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 373 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Hepatocellular carcinoma [ICD-11:2C12] | ||||
| Human hepatocellular carcinoma cell lysate (SNU-449) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 374 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ampulla of vater adenocarcinoma [ICD11: 2C16] | ||||
| Human ampulla of Vater adenocarcinoma cell lysate (SNU-478) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 375 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gastric cancer [ICD11: 2B72] | ||||
| Human gastric cancer cell lysate (SNU-5) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 376 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ampulla of vater adenocarcinoma [ICD11: 2C16] | ||||
| Human ampulla of Vater adenocarcinoma cell lysate (SNU-869) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 377 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (SSP-25) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 378 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Diffuse large B-cell lymphoma [ICD11: 2A81] | ||||
| Human diffuse large B-cell lymphoma cell lysate (SU-DHL-4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 379 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Diffuse large B-cell lymphoma [ICD11: 2A81] | ||||
| Human diffuse large B-cell lymphoma cell lysate (SU-DHL-6) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 380 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic ductal adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic ductal adenocarcinoma cell lysate (SUIT-2) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 381 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| T acute lymphoblastic leukemia [ICD11: 2A90] | ||||
| Human T lymphoblastic lymphoma cell lysate (SUP-T1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 382 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (SW1116) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 383 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Small cell lung cancer [ICD11: 2C25] | ||||
| Human small cell lung cancer cell lysate (SW1271) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 384 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Lung cancer [ICD11: 2C25] | ||||
| Human lung cancer cell lysate (SW1573) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 385 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Anaplastic astrocytoma [ICD11: 2A00] | ||||
| Human anaplastic astrocytoma cell lysate (SW1783) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 386 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Pancreatic adenocarcinoma [ICD-11:2C10] | ||||
| Human pancreatic adenocarcinoma cell lysate (SW1990) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 387 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (SW403) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 388 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (SW620) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 389 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cervical cancer [ICD11: 2C77] | ||||
| Human cervical cancer cell lysate (SW756) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 390 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Rectal cancer [ICD11: 2B92] | ||||
| Human rectal cancer cell lysate (SW837) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 391 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Colon adenocarcinoma [ICD-11:2B90] | ||||
| Human colon adenocarcinoma cell lysate (SW948) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 392 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (T24) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 393 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (T98G) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 394 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ewing sarcoma [ICD11: 2B52] | ||||
| Human ewing sarcoma cell lysate (TC-71) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 395 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (TCCSUP) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 396 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (TF-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 397 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (TE-10) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 398 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (TE-11) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 399 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (TE4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 400 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Esophageal squamous cell carcinoma [ICD11: 2B71] | ||||
| Human esophageal squamous cell carcinoma cell lysate (TE-8) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 401 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Erythroleukemia [ICD11: 2A60] | ||||
| Human erythroleukemia cell lysate (TF-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 402 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (TFK-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 403 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Gallbladder cancer [ICD11: 2C13] | ||||
| Human gallbladder cancer cell lysate (TGBC1TKB) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 404 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ampulla of vater adenocarcinoma [ICD11: 2C16] | ||||
| Human ampulla of Vater adenosquamous carcinoma cell lysate (TGBC52TKB) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 405 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute monocytic leukemia [ICD-11:2A60] | ||||
| Human acute monocytic leukemia cell lysate (THP-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 406 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Intrahepatic cholangiocarcinoma [ICD11: 2C12] | ||||
| Human intrahepatic cholangiocarcinoma cell lysate (TKKK) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 407 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian clear cell adenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian clear cell adenocarcinoma cell lysate (TOV-21G) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 408 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Ovarian serous cystadenocarcinoma [ICD11: 2C73] | ||||
| Human ovarian serous cystadenocarcinoma cell lysate (TYK-nu) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 409 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Astrocytoma [ICD-11:2F36] | ||||
| Human astrocytoma cell lysate (U-118-MG) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 410 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Osteosarcoma [ICD-11:2B51] | ||||
| Human osteosarcoma cell lysate (U2OS) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 411 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (U-87MG) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 412 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Acute monocytic leukemia [ICD-11:2A60] | ||||
| Human acute monocytic leukemia cell lysate (U-937) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 413 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (UACC-257) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 414 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (UACC-62) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 415 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Bladder cancer [ICD11: 2C94] | ||||
| Human bladder cancer cell lysate (UM-UC-3) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 416 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cell lysate (VCaP) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 417 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Renal cell carcinoma [ICD11: 2C90] | ||||
| Human renal cell carcinoma cell lysate (VMRC-RCW) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 418 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (WM-115) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 419 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (WM1552C) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 420 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Melanoma [ICD-11:2C82] | ||||
| Human melanoma cell lysate (WM 266-4) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 421 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cutaneous melanoma [ICD-11:2B00] | ||||
| Human cutaneous melanoma cell lysate (WM793) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 422 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Cholangiocarcinoma [ICD11: 2C12] | ||||
| Human cholangiocarcinoma cell lysate (YSCCC) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 423 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Invasive breast carcinoma [ICD-11:2C60] | ||||
| Human invasive breast carcinoma cell lysate (ZR-75-1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 424 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Prostate carcinoma [ICD-11:2C82] | ||||
| Human prostate carcinoma cell lysate (22RV1) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 425 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Glioblastoma [ICD11: 2A00] | ||||
| Human glioblastoma cell lysate (42-MG-BA) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 426 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| B acute lymphoblastic leukemia [ICD11: 2B33] | ||||
| Human b acute lymphoblastic leukemia cell lysate (697) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 427 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Renal cell carcinoma [ICD11: 2C90] | ||||
| Human renal cell carcinoma cell lysate (769-P) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 428 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Renal cell carcinoma [ICD11: 2C90] | ||||
| Human renal cell carcinoma cell lysate (786-O) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 429 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Thyroid gland anaplastic carcinoma [ICD11: 2D10] | ||||
| Human thyroid gland anaplastic carcinoma cell lysate (8305C) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 430 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Thyroid gland anaplastic carcinoma [ICD11: 2D10] | ||||
| Human thyroid gland anaplastic carcinoma cell lysate (8505C) | ||||
| Interaction Atlas ID |
|
|||
IA-alkyne
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| T acute lymphoblastic leukemia [ICD-11:2A90] | ||||
| Human T acute lymphoblastic leukemia cell lysate (Jurkat) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 2 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (MDA-MB-231) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 3 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Burkitt lymphoma [ICD-11:2A85] | ||||
| Human burkitt lymphoma cell lysate (Ramos) | ||||
| Interaction Atlas ID |
|
|||
|
Experiment 4 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Burkitt lymphoma [ICD-11:2A85] | ||||
| Human burkitt lymphoma cell lysate (Ramos) | ||||
| Interaction Atlas ID |
|
|||
IPM
Quantification: Probe vs (Probe+Competitor)
|
Experiment 1 Reporting the Labelling Profiles of This Probe
|
||||
| Probe concentration | ||||
| Quantitative Method | ||||
| Experimemt Name | ||||
| Competitor Name | ||||
| Competitor Concentration | ||||
| In Vitro Experiment Model |
|
|||
|
|
||||
| Breast adenocarcinoma [ICD-11:2C60] | ||||
| Human breast adenocarcinoma cell lysate (MDA-MB-231) | ||||
| Interaction Atlas ID |
|
|||
References



